Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence

The Hisayama Study

Kentaro Shikata, Toshiharu Ninomiya, Koji Yonemoto, Fumie Ikeda, Jun Hata, Yasufumi Doi, Masayo Fukuhara, Takayuki Matsumoto, Mitsuo Iida, Takanari Kitazono, Yutaka Kiyohara

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Serum pepsinogen (sPG) levels have been established as a good marker of chronic atrophic gastritis and the sequential occurrence of gastric cancer. However, there have been few prospective investigations which investigated the predictive performance of sPG for future gastric cancer incidence. Subjects and methods. We prospectively followed-up a total of 2446 community-dwelling Japanese aged ≥40 years for 10 years and used the Youden's index to determine the cutoff values of the pepsinogen I level and pepsinogen I/II ratio to accurately discriminate gastric cancer events. Predictive performance of sPG was assessed by ROC curve. Results: During the follow-up, 69 subjects developed gastric cancer. The most predictive sPG test criteria were determined to be a pepsinogen I level ≤ 59 ng/ml and pepsinogen I/II ratio ≤ 3.9. The sensitivity and specificity of these criteria to discriminate the actual occurrence of gastric cancer were 71.0% and 69.2%, respectively. The area under the ROC curve for gastric cancer occurrence increased significantly by adding the sPG test to the model that included the status of Helicobater pylori infection and other potential risk factors (from 0.742 to 0.809; p for difference in the area < 0.001). Conclusions: This study determined the optimal sPG test criteria for predicting gastric cancer occurrence over 10 years in a general Japanese population. These criteria would be effective to screen for individuals at high risk of this disease.

Original languageEnglish
Pages (from-to)669-675
Number of pages7
JournalScandinavian Journal of Gastroenterology
Volume47
Issue number6
DOIs
Publication statusPublished - Jun 1 2012

Fingerprint

Pepsinogen A
Stomach Neoplasms
Incidence
Serum
Pepsinogen C
ROC Curve
Independent Living
Atrophic Gastritis
Pylorus
Area Under Curve

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence : The Hisayama Study. / Shikata, Kentaro; Ninomiya, Toshiharu; Yonemoto, Koji; Ikeda, Fumie; Hata, Jun; Doi, Yasufumi; Fukuhara, Masayo; Matsumoto, Takayuki; Iida, Mitsuo; Kitazono, Takanari; Kiyohara, Yutaka.

In: Scandinavian Journal of Gastroenterology, Vol. 47, No. 6, 01.06.2012, p. 669-675.

Research output: Contribution to journalArticle

Shikata, Kentaro ; Ninomiya, Toshiharu ; Yonemoto, Koji ; Ikeda, Fumie ; Hata, Jun ; Doi, Yasufumi ; Fukuhara, Masayo ; Matsumoto, Takayuki ; Iida, Mitsuo ; Kitazono, Takanari ; Kiyohara, Yutaka. / Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence : The Hisayama Study. In: Scandinavian Journal of Gastroenterology. 2012 ; Vol. 47, No. 6. pp. 669-675.
@article{4006b5f0eaa840048f1eba7b054e963f,
title = "Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: The Hisayama Study",
abstract = "Background: Serum pepsinogen (sPG) levels have been established as a good marker of chronic atrophic gastritis and the sequential occurrence of gastric cancer. However, there have been few prospective investigations which investigated the predictive performance of sPG for future gastric cancer incidence. Subjects and methods. We prospectively followed-up a total of 2446 community-dwelling Japanese aged ≥40 years for 10 years and used the Youden's index to determine the cutoff values of the pepsinogen I level and pepsinogen I/II ratio to accurately discriminate gastric cancer events. Predictive performance of sPG was assessed by ROC curve. Results: During the follow-up, 69 subjects developed gastric cancer. The most predictive sPG test criteria were determined to be a pepsinogen I level ≤ 59 ng/ml and pepsinogen I/II ratio ≤ 3.9. The sensitivity and specificity of these criteria to discriminate the actual occurrence of gastric cancer were 71.0{\%} and 69.2{\%}, respectively. The area under the ROC curve for gastric cancer occurrence increased significantly by adding the sPG test to the model that included the status of Helicobater pylori infection and other potential risk factors (from 0.742 to 0.809; p for difference in the area < 0.001). Conclusions: This study determined the optimal sPG test criteria for predicting gastric cancer occurrence over 10 years in a general Japanese population. These criteria would be effective to screen for individuals at high risk of this disease.",
author = "Kentaro Shikata and Toshiharu Ninomiya and Koji Yonemoto and Fumie Ikeda and Jun Hata and Yasufumi Doi and Masayo Fukuhara and Takayuki Matsumoto and Mitsuo Iida and Takanari Kitazono and Yutaka Kiyohara",
year = "2012",
month = "6",
day = "1",
doi = "10.3109/00365521.2012.658855",
language = "English",
volume = "47",
pages = "669--675",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence

T2 - The Hisayama Study

AU - Shikata, Kentaro

AU - Ninomiya, Toshiharu

AU - Yonemoto, Koji

AU - Ikeda, Fumie

AU - Hata, Jun

AU - Doi, Yasufumi

AU - Fukuhara, Masayo

AU - Matsumoto, Takayuki

AU - Iida, Mitsuo

AU - Kitazono, Takanari

AU - Kiyohara, Yutaka

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background: Serum pepsinogen (sPG) levels have been established as a good marker of chronic atrophic gastritis and the sequential occurrence of gastric cancer. However, there have been few prospective investigations which investigated the predictive performance of sPG for future gastric cancer incidence. Subjects and methods. We prospectively followed-up a total of 2446 community-dwelling Japanese aged ≥40 years for 10 years and used the Youden's index to determine the cutoff values of the pepsinogen I level and pepsinogen I/II ratio to accurately discriminate gastric cancer events. Predictive performance of sPG was assessed by ROC curve. Results: During the follow-up, 69 subjects developed gastric cancer. The most predictive sPG test criteria were determined to be a pepsinogen I level ≤ 59 ng/ml and pepsinogen I/II ratio ≤ 3.9. The sensitivity and specificity of these criteria to discriminate the actual occurrence of gastric cancer were 71.0% and 69.2%, respectively. The area under the ROC curve for gastric cancer occurrence increased significantly by adding the sPG test to the model that included the status of Helicobater pylori infection and other potential risk factors (from 0.742 to 0.809; p for difference in the area < 0.001). Conclusions: This study determined the optimal sPG test criteria for predicting gastric cancer occurrence over 10 years in a general Japanese population. These criteria would be effective to screen for individuals at high risk of this disease.

AB - Background: Serum pepsinogen (sPG) levels have been established as a good marker of chronic atrophic gastritis and the sequential occurrence of gastric cancer. However, there have been few prospective investigations which investigated the predictive performance of sPG for future gastric cancer incidence. Subjects and methods. We prospectively followed-up a total of 2446 community-dwelling Japanese aged ≥40 years for 10 years and used the Youden's index to determine the cutoff values of the pepsinogen I level and pepsinogen I/II ratio to accurately discriminate gastric cancer events. Predictive performance of sPG was assessed by ROC curve. Results: During the follow-up, 69 subjects developed gastric cancer. The most predictive sPG test criteria were determined to be a pepsinogen I level ≤ 59 ng/ml and pepsinogen I/II ratio ≤ 3.9. The sensitivity and specificity of these criteria to discriminate the actual occurrence of gastric cancer were 71.0% and 69.2%, respectively. The area under the ROC curve for gastric cancer occurrence increased significantly by adding the sPG test to the model that included the status of Helicobater pylori infection and other potential risk factors (from 0.742 to 0.809; p for difference in the area < 0.001). Conclusions: This study determined the optimal sPG test criteria for predicting gastric cancer occurrence over 10 years in a general Japanese population. These criteria would be effective to screen for individuals at high risk of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84860843467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860843467&partnerID=8YFLogxK

U2 - 10.3109/00365521.2012.658855

DO - 10.3109/00365521.2012.658855

M3 - Article

VL - 47

SP - 669

EP - 675

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 6

ER -